The Need for COVID-19 Patient Donor Material

COVID-19 research has been the subject of intense global focus ever since it became obvious that the disease was spreading rapidly despite early efforts to contain it. As the devastating impact of COVID-19 became more apparent, countries have raced to coordinate the scientific efforts and resources necessary to fight the disease. COVID-19 itself has hampered…

$300.00
Donor #: 539
Size: 1 mL/vial
Price: $ 300.00
In Stock: 2
$300.00
Donor #: 559
Size: 1 mL/vial
Price: $ 300.00
In Stock: 3
$300.00
Donor #: 594
Size: 1 mL/vial
Price: $ 300.00
In Stock: 1
$300.00
Donor #: 593
Size: 1 mL/vial
Price: $ 300.00
In Stock: 3
$300.00
Donor #: 545
Size: 1 mL/vial
Price: $ 300.00
In Stock: 2
$300.00
Donor #: 546
Size: 1 mL/vial
Price: $ 300.00
In Stock: 2
$300.00
Donor #: 548
Size: 1 mL/vial
Price: $ 300.00
In Stock: 4

Evaluating Antitumor Immunity in a Mouse Model

Researchers cite using Cellero primary mouse spleen cells in an independent publication focused on evaluating anti-tumor immunity. [1] It is well-established in the scientific community that tumor cells use immune suppression as a way of evading the body’s immune response, thus allowing cancer to grow and spread.  Scientists have developed several strategies for dealing with…

Read more

Next Generation NK Cell Therapy

A recent independent study cited using Cellero cryopreserved primary NK cells in their bid to design a more effective form of NK cell therapy. [1] Natural killer cells (NK cells) are a critical piece of the innate immune system, displaying cytotoxic activity against virally infected cells and other physiologically stressed cells such as cancer cells.…

Read more

Reducing Risk in COVID-19 Convalescent Plasma Therapy

In a newly published study, researchers at Colorado State University and biotech company Terumo cited using COVID-19 convalescent plasma sourced from Cellero for their study on pathogen reduction technology. [1] Convalescent blood plasma is often used as a stop-gap treatment for viral diseases while other treatments are being developed. The plasma can help patients fight…

Read more

Reimagining Gene Editing for NK Cell Therapy

A new publication in the Journal of Experimental Medicine cites using cryopreserved NK cells sourced from Cellero in a study focused on improving genome editing techniques. The study’s authors, who hail from National Taiwan University, work on cancer immunotherapy. Their goal is to see the full potential of NK cells realized. Adoptive immunotherapy is proving…

Read more

Evaluating Immune Cell Cytotoxicity

Cellero showcases the latest techniques for measuring immune cell cytotoxicity in a new educational webinar. Cancer immunotherapy is a rapidly growing area of cancer treatment in which the body’s immune response to cancer cells is artificially stimulated. As the number of cancer immunotherapy treatments in clinical trials continues to increase, it is important that immune…

Read more

Disease State PBMCs Help Unlock Pathogenesis of Autoimmunity

Autoimmune diseases are chronic conditions that often occur in individuals with genetic predispositions toward that disease. The pathological mechanisms that lead to onset of disease vary and are not fully understood by modern science. Autoimmune diseases, such as celiac disease, lupus, and multiple sclerosis, are all characterized by the inappropriate inflammation and damage that result…

Read more

Cryopreserved Immune Cells to the Rescue!

  When the Covid-19 pandemic upended daily lives, biomedical research across the globe felt the strain as pandemic-related shipping and manufacturing delays began leading to supply line shortages. As lockdowns were instituted, cell therapy starting material became particularly difficult to source because the COVID-19 pandemic posed risks to donors traveling to hospitals and clinics. With…

Read more

Cellero Antigen-Specific T Cells Propel Breast Cancer Research

Antigen-Specific T Cells in Breast Cancer An independent publication from a cancer research group at Indiana University cites using Cellero antigen-specific T cell products to examine mechanisms of immune evasion.[1] Immune surveillance is the human body’s strongest defense against invasive cancer cells. The uncanny ability to evade that surveillance and grow aggressively is exactly what…

Read more